INSEAD Day 4 - 728x90

BYD logs record EV sales in 2025

It sold 2.26m EVs vs Tesla's 1.22 by Sept end.

Google to invest $6.4bn

The investment is its biggest-ever in Germany.

Pfizer poised to buy Metsera

The pharma giant improved its offer to $10bn.

Ozempic maker lowers outlook

The company posted tepid Q3 results.

Kimberly-Clark to buy Kenvue

The deal is valued at $48.7 billion.
  • The agreement will bolster cross-border ETF cooperation.

    ADX is looking to enhance ties with with leading global financial institutions, including the recent agreement with the New York Stock Exchange

    The agreement between the two bourses is set to provide a robust platform for financial growth and connectivity between the UAE and China

  • The company deals in risk management infrastructure for digital assets.

    Silicon Valley venture capital firm Lightspeed Venture Partners led the round with participation from Mubadala Capital

    Andalusia Labs is a collection of leading technology solutions addressing the security challenges prevalent in the blockchain industry

  • Reeling from a calamitous drop in advertisement revenues and public trust, news media organizations are reworking strategies to create "niche"...

    Many believe news media outlets have been distracted from their role to safeguard space for informed debate on public issues

    Several well trusted media outlets with deep pockets are battling against thinning revenues and being forced to think differently

  • Berlin, Germany -- Axel Springer said Wednesday it was partnering up with the maker of ChatGPT, OpenAI, which will pay the...

    The chatbot's answers would include material otherwise kept behind a pay-wall and offer "links to the full articles for transparency and further information," they said.

    Axel Springer CEO Matthias Doepfner has previously warned that AI threatened to "replace" journalism, while the group has been pursuing its own AI-driven ventures.

  • Doha, Qatar -- Qatar reported a total of 321 real estate transactions worth QR 1.46 billion ($400 million) in November...

    Top-performing municipalities in financial value included Doha, Al Rayyan, and Al Dhaayen. Doha led with transactions worth QR 603 million.

    Mortgage transactions totaled 88, amounting to QR 3.19 billion. Al Rayyan dominated with 38 transactions, followed by Doha with 25.

  • Riyadh, Saudi Arabia -- In the third quarter of 2023, Saudi investors engaged in sell and buy transactions on US...

    This reflects a substantial year-on-year (YoY) fall of SAR 9.15 billion, equivalent to a 40 percent decrease.

    According to a report from the Capital Market Authority (CMA), this decline in trading activity by Saudi investors represents the lowest point since Q4 2019.

  • Dubai, UAE - With the UAE-based G42's decision to align with US directives by severing ties with Chinese tech partners...

    The G42’s move follows concerns raised by US national security personnel regarding potential espionage risks from Chinese firms

    The ripple effect of G42's decision could extend to other tech companies in the Gulf Cooperation Council (GCC) region

  • Beijing, China - China and Saudi Arabia signed over 60 MoUs and agreements worth over $25 billion at the investment...

    Over 60 MoUs and agreements worth over $25 billion were signed at the China-Saudi Investment Conference

    Agreements were signed in key sectors including energy, agriculture, tourism, mining, financial services, etc

  • Dubai, UAE--Nasdaq Dubai has welcomed the first Sukuk listing by the Republic of the Philippines, "ROP Sukuk Trust", underscoring the...

    By listing sukuk on Nasdaq Dubai, the Philippines government intends to deepen its partnership with the GCC region

    The emirate of Dubai is recognised as one of the world's largest centres for sukuk issuances, with a total of US$87.61 billion

  • The drugmaker will complete its US$43bn buyout this week.

    Pfizer Chief Executive Albert Bourla said the buyout of Seagen is "good for patients in the battle against cancer"

    Based in Washington state, Seagen came to major drugmakers' attention with its work on antibody-drug conjugates